Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$45.01
-0.27-0.60%
At close: -
$45.01
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Mirum Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:MIRM | Benzinga
Mirum Pharmaceuticals Inc has a consensus price target of $59 based on the ratings of 16 analysts. The high is $77 issued by Raymond James on May 13, 2025. The low is $38 issued by Citigroup on May 9, 2024. The 3 most-recent analyst ratings were released by Raymond James, JMP Securities, and HC Wainwright & Co. on May 13, 2025, May 9, 2025, and February 28, 2025, respectively. With an average price target of $75 between Raymond James, JMP Securities, and HC Wainwright & Co., there's an implied 66.63% upside for Mirum Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
JMP Securities
HC Wainwright & Co.
Baird
Citizens Capital Markets
1calculated from analyst ratings
Analyst Ratings for Mirum Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 71.07% | Raymond James | Steven Seedhouse57% | $73 → $77 | Maintains | Strong Buy | Get Alert |
| 05/09/2025 | Buy Now | 68.85% | JMP Securities | Jonathan Wolleben68% | $74 → $76 | Maintains | Market Outperform | Get Alert |
| 02/28/2025 | Buy Now | 59.96% | HC Wainwright & Co. | Ed Arce57% | $66 → $72 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 22.2% | Baird | Brian Skorney57% | $50 → $55 | Maintains | Outperform | Get Alert |
| 02/24/2025 | Buy Now | 64.41% | Citizens Capital Markets | Jonathan Wolleben68% | $74 → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/13/2024 | Buy Now | 46.63% | HC Wainwright & Co. | Ed Arce57% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 51.08% | Citigroup | David Lebowitz52% | $65 → $68 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 11.09% | Baird | Brian Skorney57% | $44 → $50 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | 8.86% | Leerink Partners | Mani Foroohar47% | $47 → $49 | Maintains | Outperform | Get Alert |
| 10/11/2024 | Buy Now | 46.63% | HC Wainwright & Co. | Ed Arce57% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 33.3% | Cantor Fitzgerald | Josh Schimmer50% | $50 → $60 | Maintains | Overweight | Get Alert |
| 08/08/2024 | Buy Now | 46.63% | Evercore ISI Group | Gavin Clark-Gartner36% | $62 → $66 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | -2.24% | Baird | Brian Skorney57% | $39 → $44 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 46.63% | HC Wainwright & Co. | Ed Arce57% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 07/08/2024 | Buy Now | 46.63% | HC Wainwright & Co. | Ed Arce57% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 46.63% | HC Wainwright & Co. | Ed Arce57% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2024 | Buy Now | 46.63% | Stifel | Dae Gon Ha46% | $48 → $66 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | 42.19% | Citigroup | David Lebowitz52% | $38 → $64 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | -13.35% | JP Morgan | Jessica Fye62% | $31 → $39 | Maintains | Overweight | Get Alert |
| 06/18/2024 | Buy Now | 51.08% | JMP Securities | Jonathan Wolleben68% | $66 → $68 | Maintains | Market Outperform | Get Alert |
| 06/18/2024 | Buy Now | 26.64% | Morgan Stanley | Michael Ulz60% | $53 → $57 | Maintains | Overweight | Get Alert |
| 06/17/2024 | Buy Now | 46.63% | HC Wainwright & Co. | Ed Arce57% | $58 → $66 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 6.64% | Stifel | Dae Gon Ha46% | $48 → $48 | Reiterates | Buy → Buy | Get Alert |
| 06/17/2024 | Buy Now | -13.35% | Baird | Brian Skorney57% | $34 → $39 | Maintains | Outperform | Get Alert |
| 06/07/2024 | Buy Now | 28.86% | HC Wainwright & Co. | Ed Arce57% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 28.86% | HC Wainwright & Co. | — | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 17.75% | Morgan Stanley | Michael Ulz60% | $57 → $53 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | -11.13% | Cantor Fitzgerald | Josh Schimmer50% | $40 → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 28.86% | HC Wainwright & Co. | Ed Arce57% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 46.63% | JMP Securities | Jonathan Wolleben68% | $72 → $66 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | Buy Now | -15.57% | Citigroup | David Lebovitz64% | $37 → $38 | Maintains | Buy | Get Alert |
| 04/17/2024 | Buy Now | 6.64% | Stifel | Dae Gon Ha46% | → $48 | Initiates | → Buy | Get Alert |
| 04/02/2024 | Buy Now | 28.86% | HC Wainwright & Co. | Ed Arce57% | $58 → $58 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | -4.47% | Leerink Partners | Mani Foroohar47% | $44 → $43 | Maintains | Outperform | Get Alert |
| 03/14/2024 | Buy Now | 59.96% | JMP Securities | Jonathan Wolleben68% | $69 → $72 | Maintains | Outperform | Get Alert |
| 03/14/2024 | Buy Now | 28.86% | HC Wainwright & Co. | Ed Arce57% | $45 → $58 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | -11.13% | Cantor Fitzgerald | Josh Schimmer50% | $35 → $40 | Maintains | Overweight | Get Alert |
| 02/29/2024 | Buy Now | -22.24% | Cantor Fitzgerald | Josh Schimmer50% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 02/29/2024 | Buy Now | -0.02% | HC Wainwright & Co. | Ed Arce57% | $58 → $45 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 53.3% | JMP Securities | Jonathan Wolleben68% | $64 → $69 | Maintains | Market Outperform | Get Alert |
| 01/11/2024 | Buy Now | 42.19% | JMP Securities | Jonathan Wolleben68% | $64 → $64 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/19/2023 | Buy Now | 42.19% | Raymond James | Steven Seedhouse57% | $78 → $64 | Maintains | Strong Buy | Get Alert |
| 12/18/2023 | Buy Now | 28.86% | HC Wainwright & Co. | Ed Arce57% | $60 → $58 | Maintains | Buy | Get Alert |
| 11/27/2023 | Buy Now | 11.09% | Cantor Fitzgerald | Josh Schimmer50% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | Buy Now | -17.8% | JP Morgan | Jessica Fye62% | → $37 | Reinstates | → Overweight | Get Alert |
| 11/15/2023 | Buy Now | 11.09% | Cantor Fitzgerald | Joshua Schimmer43% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/13/2023 | Buy Now | 33.3% | Morgan Stanley | Michael Ulz60% | → $60 | Initiates | → Overweight | Get Alert |
| 11/03/2023 | Buy Now | 33.3% | HC Wainwright & Co. | Ed Arce57% | $63 → $60 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 11.09% | Cantor Fitzgerald | Joshua Schimmer43% | → $50 | Initiates | → Overweight | Get Alert |
| 10/18/2023 | Buy Now | 55.52% | JMP Securities | Jonathan Wolleben68% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/18/2023 | Buy Now | 71.07% | Raymond James | Steven Seedhouse57% | $84 → $77 | Maintains | Strong Buy | Get Alert |
| 10/17/2023 | Buy Now | 37.75% | Evercore ISI Group | Gavin Clark-Gartner36% | → $62 | Reinstates | → Outperform | Get Alert |
| 10/09/2023 | Buy Now | 55.52% | JMP Securities | Jonathan Wolleben68% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/20/2023 | Buy Now | 55.52% | JMP Securities | Jonathan Wolleben68% | → $70 | Initiates | → Market Outperform | Get Alert |
| 09/13/2023 | Buy Now | 39.97% | HC Wainwright & Co. | Ed Arce57% | → $63 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | Buy Now | 86.63% | Raymond James | Steven Seedhouse57% | $79 → $84 | Maintains | Strong Buy | Get Alert |
| 08/04/2023 | Buy Now | 39.97% | HC Wainwright & Co. | Ed Arce57% | → $63 | Reiterates | → Buy | Get Alert |
| 08/04/2023 | Buy Now | 75.52% | Raymond James | Steven Seedhouse57% | $82 → $79 | Maintains | Strong Buy | Get Alert |
| 07/18/2023 | Buy Now | 39.97% | HC Wainwright & Co. | Ed Arce57% | $61 → $63 | Maintains | Buy | Get Alert |
| 07/18/2023 | Buy Now | 82.18% | Raymond James | Steven Seedhouse57% | $81 → $82 | Maintains | Strong Buy | Get Alert |
| 06/15/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | → $61 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | → $61 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | → $61 | Reiterates | → Buy | Get Alert |
| 04/13/2023 | Buy Now | 79.96% | Raymond James | Steven Seedhouse57% | $83 → $81 | Maintains | Strong Buy | Get Alert |
| 04/06/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | → $61 | Reiterates | → Buy | Get Alert |
| 03/15/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | → $61 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | → $61 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 84.4% | Raymond James | Steven Seedhouse57% | $84 → $83 | Maintains | Strong Buy | Get Alert |
| 02/15/2023 | Buy Now | 35.53% | HC Wainwright & Co. | Ed Arce57% | $69 → $61 | Reiterates | → Buy | Get Alert |
| 01/10/2023 | Buy Now | 86.63% | Raymond James | Steven Seedhouse57% | $88 → $84 | Maintains | Strong Buy | Get Alert |
| 01/10/2023 | Buy Now | -13.35% | SVB Leerink | Mani Foroohar47% | $50 → $39 | Maintains | Outperform | Get Alert |
| 12/14/2022 | Buy Now | 11.09% | SVB Leerink | Mani Foroohar47% | $49 → $50 | Maintains | Outperform | Get Alert |
| 11/14/2022 | Buy Now | 53.3% | HC Wainwright & Co. | Ed Arce57% | $68 → $69 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | -24.46% | Citigroup | David Lebowitz52% | $38 → $34 | Maintains | Buy | Get Alert |
| 10/25/2022 | Buy Now | 95.51% | Raymond James | Steven Seedhouse57% | $75 → $88 | Maintains | Strong Buy | Get Alert |
| 10/25/2022 | Buy Now | 51.08% | HC Wainwright & Co. | Ed Arce57% | $63 → $68 | Maintains | Buy | Get Alert |
| 09/01/2022 | Buy Now | -15.57% | Citigroup | David Lebowitz52% | → $38 | Initiates | → Buy | Get Alert |
| 05/24/2022 | Buy Now | 15.53% | SVB Leerink | Mani Foroohar47% | $50 → $52 | Maintains | Outperform | Get Alert |
| 05/23/2022 | Buy Now | 53.3% | HC Wainwright & Co. | Ed Arce57% | $64 → $69 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Mirum Pharmaceuticals (MIRM) stock?
The latest price target for Mirum Pharmaceuticals (NASDAQ:MIRM) was reported by Raymond James on May 13, 2025. The analyst firm set a price target for $77.00 expecting MIRM to rise to within 12 months (a possible 71.07% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mirum Pharmaceuticals (MIRM)?
The latest analyst rating for Mirum Pharmaceuticals (NASDAQ:MIRM) was provided by Raymond James, and Mirum Pharmaceuticals maintained their strong buy rating.
When was the last upgrade for Mirum Pharmaceuticals (MIRM)?
There is no last upgrade for Mirum Pharmaceuticals
When was the last downgrade for Mirum Pharmaceuticals (MIRM)?
There is no last downgrade for Mirum Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Mirum Pharmaceuticals (MIRM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mirum Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mirum Pharmaceuticals was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating Mirum Pharmaceuticals (MIRM) correct?
While ratings are subjective and will change, the latest Mirum Pharmaceuticals (MIRM) rating was a maintained with a price target of $73.00 to $77.00. The current price Mirum Pharmaceuticals (MIRM) is trading at is $45.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
